Phenotypical features of a heterozygous form of familial hypercholesterolemia

被引:0
|
作者
Malyshev, P. P.
Rozhkova, T. A.
Solovyeva, E. Yu.
Meshkov, A. N.
Kaminnaya, V. I.
Kukharchuk, V. V.
机构
来源
TERAPEVTICHESKII ARKHIV | 2007年 / 79卷 / 09期
关键词
familial hypercholesterolemia; xanthomas; cholesterol;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To conduct a quantitative and qualitative analysis of phenotypical manifestations in patients with a heterozygous form of familial hypercholesterolemia (FHC) and to reveal factors involved in their development. Material and methods. A total of 247 patients with a clinical diagnosis of heterozygous FHC participated in the trial. Clinical manifestations of the disease in men and women were analysed and compared. Blood lipids were compared to those in the controls. A correlation analysis was used to reveal correlations between symptoms of the disease and lipid levels in the blood. Results. Tendon xanthomas were most frequent (79916) clinical sign with location primarily in Achilles' tendon. Incidence of basic clinical manifestations increased with age and significantly correlated with LDLP cholesterol. Two clinical signs were seen in 113 of the patients, three - in 13% (sex differences were insignificant). Mean levels of total cholesterol and LDLP serum cholesterol in heterozygous patients were 1.9 and 2.5 times higher than in the controls. Total cholesterol was significantly higher in women. A mean level of HDLP cholesterol was significantly lower while triglycerides were higher than in the control group. The disease symptoms manifested in men 5 years earlier than in women, FHC was diagnosed in men 7 5 years earlier. Conclusion. Patients with heterozygous FHC are characterized by higher levels of LDLP cholesterol, lower level of HDLP cholesterol and higher triglycerides in the serum than in healthy controls. Sex-related differences by severity and prevalence of basic symptoms in heterozygous FHC patients were not found. The time of clinical symptoms appearance and diagnosis evidences for more rapid progression of the disease in men.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 50 条
  • [31] Mortality from heterozygous familial hypercholesterolemia.
    Sijbrands, EJG
    Defesche, JC
    Lombardi, P
    Westendorp, RJG
    Smelt, AHM
    Kastelein, JJP
    [J]. CIRCULATION, 1996, 94 (08) : 4321 - 4321
  • [32] Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia
    Civeira, F
    [J]. ATHEROSCLEROSIS, 2004, 173 (01) : 55 - 68
  • [33] Genetic screening for homozygous and heterozygous familial hypercholesterolemia
    Izar, Maria C.
    Machado, Valeria A.
    Fonseca, Francisco A.
    [J]. APPLICATION OF CLINICAL GENETICS, 2010, 3 : 147 - 157
  • [34] Lipoprotein(a) metabolism in patients with heterozygous familial hypercholesterolemia
    Parhofer, KG
    Ritter, MM
    Geiss, C
    Schwandt, P
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 146 - 146
  • [35] Clinical management of Heterozygous Familial Hypercholesterolemia (FH)
    Soran, H.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 41 - 41
  • [36] Heterozygous familial hypercholesterolemia: prevalence and control rates
    Polychronopoulos, Georgios
    Tzavelas, Marios
    Tziomalos, Konstantinos
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2021, 16 (04) : 175 - 179
  • [37] ENDOTHELIUM FUNCTION IN CHILDREN WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Slastnikova, E. S.
    Sadykova, D. I.
    Galimova, L. F.
    Khaliullina, C. D.
    [J]. ATHEROSCLEROSIS, 2022, 355 : E83 - E83
  • [38] Emerging Treatments for Heterozygous and Homozygous Familial Hypercholesterolemia
    Baum, Seth J.
    Soifer, Daniel
    Duell, P. Barton
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2016, 17 (1-2) : 17 - 25
  • [39] Colesevelam: In pediatric patients with heterozygous familial hypercholesterolemia
    Perry C.M.
    [J]. Pediatric Drugs, 2010, 12 (2) : 133 - 140
  • [40] Heterozygous familial hypercholesterolemia: Diagnosis and drug therapy
    Malyshev, PP
    [J]. KARDIOLOGIYA, 2000, 40 (10) : 63 - 69